Patient Cooperation Committee Patient Organization Advisory Board Past Meeting Summaries
-
What is and should be the way of providing information on pharmaceutical products?
-
Introduction from JPMA and exchange of opinions on drug development (clinical trials)
-
Exchange of opinions on expectations and requests to the pharmaceutical industry with newly appointed advisors
-
Visit to Takeda's Shonan Research Center and exchange of opinions
-
Opinion exchange on "Legislation on Clinical Research" and "Questionnaire on Medical Information
Ikuo Miyamoto, Leader of MA/Clinical Research TF, JPMA Drug Evaluation Committee
Masaya Takamoto, Leader of TF for "Industrial Vision 2025", Patient Cooperation Committee, JPMA
Yasuhiro Marumoto, Leader of Questionnaire TF, Patient Cooperation Committee, JPMA -
Discussion on "JPMA Industry Vision 2025" and "Trial introduction of cost-effectiveness evaluation
Kazuhiro Momose, Leader of Vision Promotion Project, JPMA Industrial Policy Committee
Reitsune Miura, Leader of Medical Technology Evaluation Group, JPMA Industrial Policy Committee, Industrial Promotion Subcommittee